Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence Pushkar Shinde / Monday, November 11, 2024 / Article rating: 5.0 With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams Pushkar Shinde / Wednesday, November 6, 2024 / Article rating: 3.8 Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Sensex Dips While Mid & Small-Caps Shine Bright! Sensex Dips While Mid & Small-Caps Shine Bright! Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform Pushkar Shinde / Tuesday, September 3, 2024 / Article rating: No rating Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform
Midday Market Mix: Sensex & Nifty Slip, But Midcaps & Smallcaps Shine Bright! Midday Market Mix: Sensex & Nifty Slip, But Midcaps & Smallcaps Shine Bright! Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive Pushkar Shinde / Tuesday, September 3, 2024 / Article rating: No rating Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive
Exciting developments in the pharma industry that could skyrocket your portfolio; have a look Exciting developments in the pharma industry that could skyrocket your portfolio; have a look Previously revolutionising the IT industry, these technological advancements are currently enhancing efficiency, productivity and cost control in the pharmaceutical industry Mandar Wagh / Wednesday, January 31, 2024 / Article rating: 4.3 Previously revolutionising the IT industry, these technological advancements are currently enhancing efficiency, productivity and cost control in the pharmaceutical industry
Don’t miss the action in this pharmaceutical stock: The Cup and handle pattern breakout is seen with huge volumes! Don’t miss the action in this pharmaceutical stock: The Cup and handle pattern breakout is seen with huge volumes! Notably, the RSI has entered a super bullish territory, indicating a significant shift in momentum. Karan Dsij / Monday, December 25, 2023 / Article rating: 4.7 The Nifty Pharmaceutical index has surged by an impressive 30 per cent on a year-to-date basis in 2023, significantly outperforming the Nifty 50 index. Against the backdrop of India experiencing a single-day spike of 628 new COVID-19 cases
Upcoming collaboration: Two leading pharma company stocks to watch out for Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns Kiran Shroff / Wednesday, November 9, 2022 / Article rating: 4.5 Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.
NSE revises circuit limit of two stocks, one of them hit a fresh 52-week high today; do you own it? NSE revises circuit limit of two stocks, one of them hit a fresh 52-week high today; do you own it? The stock was among the top gainers list on Wednesday as the stock jumped more than 14.5 per cent Karan Dsij / Wednesday, September 28, 2022 / Article rating: 3.9 On National Stock Exchange (NSE) has revised the circuit limit of two stocks. Out of two stocks, one stock has seen circuit limit being narrowed while for the other one, circuit filter got widened.